Read the winning stories from the 2025 PBS KIDS Writers Contest at WVPB!
Nominate an exceptional West Virginia teacher today!
On Demand
On Demand
Watch locally produced documentaries & more.
On Demand
On Demand
West Virginia Morning
Inside Appalachia
West Virginia Week
Mountain Stage
Us & Them
The Legislature Today
Send us your comments and questions.
Stream our board meetings.
Check out the latest WVPB news.
Sign up for our newsletter and get weekly updates.
Meet the WVPB staff.
WV Educational Broadcasting Authority, the WVPB Foundation, and the Friends of WVPB.
Come work with us!
Sponsor impactful and engaging media and entertainment.
Use your IRA to make a gift to WVPB.
Become a member with your gift of $1,000 or more.
Make WVPB part of your legacy.
Manage your membership account.
Learn how you can Protect and Sustain West Virginia Public Broadcasting.
Attorney General Patrick Morrisey says West Virginia will receive a $253,500 share of a settlement with Bristol-Myers Squibb involving allegations that it promoted the anti-psychotic drug Abilify for unapproved uses.
Morrisey announced the state’s share of the $19.5 million settlement in a news release. Forty-two other states were involved in the legal action.
Abilify is approved by the U.S. Food and Drug Administration to treat schizophrenia, bipolar disorder, major depressive disorder and Tourette’s disorder in adults and children. California alleged that Bristol-Myers Squibb promoted the schizophrenia drug for unapproved uses on children and for elderly patients with dementia.
Students from WVU and Marshall have become regular recipients of the scholarship in recent years.
Continue Reading Take Me to More NewsThe Fourth Circuit Court of Appeals upheld a lower court's decision that West Virginia can restrict the sale of abortion medication.
Continue Reading Take Me to More NewsMatt Herridge has announced he will resign his position as chair of the state GOP on July 26.
Continue Reading Take Me to More NewsThe state Board of Education has already taken steps to pursue litigation in a related matter.
Continue Reading Take Me to More News
